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Abstract s4U-containing transcripts of tRNAPhe gene have
been prepared by complete substitution of 16 U residues or by
random incorporation of s4U residues followed by affinity
electrophoresis isolation of s4U-monosubstituted tRNA tran-
scripts. Both analogs have been cross-linked to Thermus
thermophilus phenylalanyl-tRNA synthetase (PheRS) and the
specificity of the cross-linking has been demonstrated. Functional
activity of the covalent complex of PheRS with the s4U-
monosubstituted transcript has been shown by aminoacylation
of 60% of the enzyme-cross-linked tRNA. This is the first
instance in which biological activity of aminoacyl-tRNA
synthetase and cross-linked tRNA in a specific complex has
been revealed.
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1. Introduction
Recognition and speci¢c aminoacylation of tRNA by ami-
noacyl-tRNA synthetases (aaRSs) is a key step that governs
the accuracy of protein synthesis. Recently, the study of
tRNA aminoacylation has mainly focused on determination
of the tRNA structural elements required for speci¢c recog-
nition by cognate synthetases (reviewed in [1,2]). High-resolu-
tion X-ray crystallographic data have been obtained for some
complexes of aaRSs with tRNAs [2^5]. From a⁄nity labeling
and site-directed mutagenesis of a number of aaRSs the pep-
tide regions interacting with the tRNA recognition elements
have been identi¢ed [2].
PheRS is a K2L2 heterotetramer that belongs to class II of
aaRSs. The three-dimensional structure of Thermus thermo-
philus PheRS cocrystallized with its cognate tRNA has been
resolved [5]. The amino acid residues responsible for speci¢c
interaction with three nucleotides of the anticodon and with
the 3P-terminal CCA sequence of tRNAPhe have been de¢ned.
These nucleotides are critically important for e⁄cient amino-
acylation with this enzyme [6,7]. Little contribution of some
nucleotides involved in the tRNAPhe tertiary interactions and
the nucleotide in position 20 to tRNAPhe recognition has been
shown by in vitro kinetics measurement for mutant tRNAPhe
gene transcripts [6]. Additional contacts with tRNA backbone
in the anticodon stem, the D-arm, the acceptor stem and the
variable loop have been found by iodine footprinting [8]. Sev-
eral nucleotides of these regions have been proposed to be in
close contact with PheRS in the crystal structure, but their
interaction with the enzyme has not been examined in detail.
In the present work we have used s4U-containing tran-
scripts of tRNAPhe gene for a⁄nity labeling of T. thermophi-
lus PheRS. Modi¢ed polynucleotides containing photoreactive
s4U residues have been extensively used for investigating
RNA-protein interactions in di¡erent systems other than
aaRSs [9,10]. The most important among many advantages
of such RNA derivatives discussed in [9,10] is the zero length
of the reactive group providing identi¢cation of the structural
regions of two macromolecules, which are in close contact. It
was of particular interest to examine the functional activity of
the tRNAPhe-PheRS covalent complex. No data on amino-
acylation of tRNA derivatives cross-linked to aaRSs have
been reported so far. The results of these experiments pro-
vided direct evidence for high speci¢c labeling of the tRNA
binding site of PheRS.
2. Materials and methods
2.1. Materials
ATP, GTP, CTP, UTP and spermidine were purchased from Sigma.
Acrylamide, N,NP-bisacrylamide and tris(hydroxymethyl)amino-
methane were obtained from Fluka and dithiothreitol from Serva.
Sephadex G-200 (10^40 Wm) was purchased from Pharmacia Fine
Chemicals. L-Phenyl[2,3-3H]alanine (1.96 TBq/mmol) was a product
of St. Petersburg Institute of Applied Chemistry. [U-14C]ATP (17
GBq/mmol) and L-[U-14C]phenylalanine (13 GBq/mmol) were pur-
chased from UVVVR. 4-Thiouridine-5P-triphosphate (s4UTP) was
synthesized from 4-thiouridine-5P-monophosphate (Serva) by V.S. Bo-
gachev (Novosibirsk Institute of Bioorganic Chemistry). (N-Acryloyl-
amino)phenylmercuric chloride (APM) was kindly provided by G.L.
Igloi (Universitat Freiburg, Germany). Plasmid DNA containing the
Escherichia coli tRNAPhe gene under the control of the phage T7
promoter was a generous gift of O.C. Uhlenbeck (University of Col-
orado, USA).
PheRS with a speci¢c activity of 350 units/mg was isolated from
T. thermophilus HB8 as described [11]. One unit of PheRS activity is
de¢ned as the amount of enzyme which catalyzes phenylalanylation of
1 nmol of tRNAPhe for 1 min at 37‡C. T7 RNA polymerase was
isolated from E. coli BL21 harboring the plasmid pAR1219. T. ther-
mophilus tRNAPhe with acceptor activity of 1700 pmol of phenylala-
nine/A260 unit was isolated as described [12,13]. tRNAPhe lacking the
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3P-terminal nucleotide, tRNAPhe(3pA76), was prepared by subjecting
tRNAPhe to one cycle of the Whitfeld degradation procedure [14].
2.2. Preparation of thiolated tRNAPhe gene transcripts
Run-o¡ transcription with T7 RNA-polymerase of BstNI-linearized
DNA was performed as described [15] with some modi¢cations. The
completely thiolated tRNAPhe gene transcript was synthesized in the
presence of s4UTP without UTP and isolated by a denaturing 10%
PAGE. To prepare s4U-monosubstituted (monothiolated) transcript,
the transcription was carried out in the presence of s4UTP and UTP
mixed in a 1:4 molar ratio. tRNAs with di¡erent s4U content were
fractionated on a denaturing 10% PAG containing 2 Wg/ml APM
according to described procedures [16,17]. The s4U content of the
separated fractions was determined from the absorbance ratio at
330 and 260 nm as described [18]. 14C-labeled transcripts (speci¢c
activity 2000 cpm/pmol) were prepared in the presence of 0.2 mM
[14C]ATP added to 0.8 mM ATP in the transcription reaction mixture.
2.3. Cross-linking of thiolated tRNAPhe gene transcripts to PheRS and
isolation of the covalent tRNAPhe-PheRS complex
The 40^50-Wl reaction mixture contained 1 WM PheRS, 2^3 WM
[1s4U]-tRNAPhe or 2^7 WM [16s4U]-tRNAPhe, 15 mM MgCl2, 50
mM Tris-HCl, pH 8.5. Irradiation of the samples was performed
with 337 nm light of a nitrogen laser (model LGI-21) at 25‡C for
30 min. Control experiments were carried out with the enzyme irra-
diated alone or in the presence of 2 WM wild-type transcript of the
tRNAPhe gene. After irradiation 1-Wl aliquots were withdrawn for
measurement of a residual enzyme activity. The remaining irradiated
mixture was applied on a 3.5U220-mm Sephadex G-200 column
equilibrated with 50 mM Tris-HCl, pH 8.5. The sample was eluted
with the same bu¡er at a £ow rate of 1 ml/h. The absorbance at
260 nm and 280 nm was monitored with a Millichrome detector.
The peak containing protein was pooled, 10- and 20-Wl aliquots
were taken for measurement of 14C radioactivity. The remainder of
the pooled material was assayed for aminoacylation activity as
described below. Protein concentration was measured in the control
sample with the enzyme irradiated in the absence of tRNA.
2.4. Aminoacylation of tRNA
PheRS activity in aminoacylation reaction was determined as de-
scribed [6,11]. The 100-Wl reaction mixture contained 10 nM PheRS,
2 WM tRNAPhe (Km 0.12 WM), 10 WM L-[14C]phenylalanine, 5 mM
ATP, 9 mM MgCl2, 50 mM Tris-HCl, pH 8.5. Kinetic parameters for
tRNAPhe gene transcripts were determined as described [6]. All ami-
noacylation kinetics of transcripts were carried out in a bu¡er con-
taining 15 mM MgCl2. Initial rates for phenylalanylation were meas-
ured in the presence of 10 nM PheRS. The phenylalanylation level
(charging capacity) was determined with a concentration range of 50^
200 nM tRNAPhe analog and 10^100 nM PheRS. All aminoacylation
kinetics presented in this work were carried out at 37‡C. Aminoacyl-
ation of tRNAPhe analog cross-linked to PheRS was performed in the
following way. The enzyme was separated from uncoupled tRNA by
gel ¢ltration (see Section 2.3). 25- and 50-Wl aliquots of the pooled
protein were taken for aminoacylation assay. MgCl2, ATP and
[3H]phenylalanine at the concentrations used for aminoacylation re-
action were added to the enzyme in a total volume of 0.1 ml. 15-Wl
aliquots were taken at various times to measure [3H]phenylalanine
incorporation into the trichloroacetic acid-precipitable fraction as de-
scribed [11]. The e¡ect of the unchargeable analog tRNAPhe(3pA76)
on aminoacylation of the PheRS-cross-linked tRNAPhe was deter-
mined in a concentration range of 1^6 WM tRNAPhe(3pA76) and
of 15^40 nM cross-linked tRNA. In parallel, the enzyme-cross-linked
tRNA was replaced with the same amount of free wild-type tRNAPhe
transcript.
3. Results and discussion
s4U-containing analogs of tRNAPhe were synthesized by in
vitro transcription of E. coli tRNAPhe gene with T7 RNA
polymerase in the presence of s4UTP. The completely thio-
lated transcript [16s4U]-tRNAPhe prepared in the absence of
UTP contains 16 residues of s4U per molecule (Fig. 1). The
monothiolated analog [1s4U]-tRNAPhe was prepared by ran-
dom incorporation of s4U in the presence of both UTP and
s4UTP followed by isolation of s4U-monosubstituted tRNA
fraction on a⁄nity gel. The sulfur-containing nucleic acids
were retarded by speci¢c interaction with an organomercurial
derivative (APM) present in the gel, which made it possible to
separate transcripts with di¡erent s4U content [16,17].
Kinetic parameters for aminoacylation with T. thermophilus
PheRS of thiolated transcripts were determined (Table 1). The
data were compared with Km and kcat values for the wild-type
E. coli tRNAPhe transcript known to be the e⁄cient heterol-
ogous substrate for T. thermophilus PheRS with catalytic e⁄-
ciency similar to that of T. thermophilus tRNAPhe [6]. No
di¡erences in aminoacylation kinetic parameters for mono-
thiolated and unthiolated transcripts were observed. The sub-
stitution of 16 U residues by s4U reduced the relative catalytic
e⁄ciency 14-fold primarily due to an increased Km.
s4U-containing tRNAPhe analogs were cross-linked to
PheRS by UV irradiation at 337 nm. To determine the yield
of cross-linking reaction, the irradiated mixtures were sepa-
rated by SDS-PAGE (data not shown). 17% of the input
[1s4U]-tRNAPhe and 34% of [16s4U]-tRNAPhe were cross-
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Fig. 1. Secondary structure of the tRNAPhe gene transcript. Circled
positions were substituted in the completely thiolated analog
[16s4U]-tRNAPhe. The monothiolated analog [1s4U]-tRNAPhe con-
tained one s4U residue randomly distributed between the numbered
positions.
Table 1
Kinetic parameters of aminoacylation with T. thermophilus PheRS
for s4U-containing tRNAPhe gene transcripts
tRNAPhe Km kcat kcat/Kma
(transcript) (WM)
Wild-type 0.19 (1.0) (1.0)
[1s4U]-tRNAPhe 0.20 1.0 0.95
[16s4U]-tRNAPhe 2.3 0.85 0.070
akcat and kcat/Km are normalized to the wild-type transcript.
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linked to PheRS after irradiation of the enzyme with a 2-fold
molar excess of each tRNA analog over the protein. The co-
valent coupling of the enzyme and the tRNA analog was
accompanied by a loss of the enzyme activity. One mol of
PheRS was completely inactivated by the incorporation of
1.8 mol of [16s4U]-tRNAPhe. The stoichiometry of labeling
suggests that T. thermophilus PheRS is a functional dimer
like E. coli PheRS [19]. Cross-linking was completely inhibited
by addition of the excess of T. thermophilus tRNAPhe but not
by addition of a non-cognate tRNA, indicating the speci¢city
of the labeling reaction.
We examined aminoacylation activity of the covalent com-
plexes of PheRS with s4U-containing tRNAPhe analogs. En-
zyme-cross-linked tRNAPhe was separated from unbound
tRNAPhe analog by gel ¢ltration on Sephadex G-200. Fig.
2a shows the elution pro¢le of the irradiated mixture of
PheRS and 14C-labeled analog [1s4U]-tRNAPhe. Peak 1 con-
tains the covalent tRNA-enzyme complex (or complexes dif-
fering in cross-linked position of tRNA) and a free enzyme
that cannot be separated by this procedure. Peak 2 corre-
sponds to the free tRNA analog. The amount of the bound
tRNAPhe was determined by measuring 14C-radioactivity of
the pooled material of peak 1. The data on residual enzyme
activity and level of cross-linking are presented in Table 2.
Addition of [3H]phenylalanine and Mg2-ATP to the mixture
of covalent complex and free PheRS (the pooled material of
peak 1, Fig. 2a) led to incorporation of 3H-radioactivity into
the cross-linked tRNAPhe (Fig. 2b). In the control experiment
with PheRS irradiated in the presence of the wild-type
tRNAPhe gene transcript neither 14C-labeled transcript nor
[3H]phenylalanine incorporated into the trichloroacetic acid-
insoluble fraction was detected in the protein peak, indicating
that the isolated enzyme was not contaminated with the free
tRNA. The data of the experiments with varying concentra-
tions of the analog showed that about 60% of the enzyme-
cross-linked monothiolated tRNAPhe is phenylalanylated. It
should be mentioned that the activity of PheRS after the
cross-linking reaction was determined as an initial rate of
aminoacylation of tRNAPhe added at sub-saturating concen-
tration with catalytic amount of the enzyme (see Section 2).
The contribution of the phenylalanylated enzyme-cross-linked
tRNA analog to the total amount of phenylalanyl-tRNAPhe
formed at these conditions did not exceed 1%. The loss of the
enzyme activity is presumably due to the blockage of the
tRNA binding site by the cross-linked tRNA.
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Fig. 2. Gel ¢ltration of the covalent complex of PheRS and [1s4U]-
tRNAPhe on Sephadex G-200 column (a). 30 Wl of the irradiated
mixture was applied on a column. The protein material indicated
with arrows was pooled. Aminoacylation of [1s4U]-tRNAPhe cross-
linked to PheRS (b). 25-Wl (1) and 50-Wl (2) aliquots of the pooled
material of peak 1 (a) were mixed with [3H]phenylalanine and
MgCl2-ATP. Each aliquot taken for measurement of
[3H]phenylalanine incorporation contained 0.28 pmol (1) or 0.56
pmol (2) of the enzyme-cross-linked tRNAPhe analog.
Table 2
Cross-linking of s4U-containing tRNAPhe gene transcripts to PheRS and aminoacylation of the cross-linked tRNAPhe
tRNAPhe gene
transcript (WM)
Residual enzyme
activity (%)
Mol of cross-linked
tRNAPhe/mol of the enzyme
Mol of [3H]Phe incorporated/mol
of cross-linked tRNAPHe
Wild-type (2) 100 0 0
[1s4U]-tRNAPhe (2) 80 0.36 0.61
[1s4U]-tRNAPhe (3) 79 0.38 0.57
[16s4U]-tRNAPhe (4) 38 1.10 0.01
[16s4U]-tRNAPhe (7) 16 1.50 0.01
Fig. 3. E¡ect of tRNAPhe(3pA76) on aminoacylation of [1s4U]-
tRNAPhe cross-linked to PheRS (1, 2) or free (the wild-type tran-
script) tRNAPhe (3, 4). (E) No addition, (F) plus 4 WM
tRNAPhe(3pA76). The concentrations of PheRS (in the experiment
with the enzyme-cross-linked tRNA the total concentration of free
and cross-linked PheRS) and tRNAPhe (the PheRS-cross-linked ana-
log or the wild-type transcript) were 40 nM and 15 nM, respec-
tively.
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The observed aminoacylation of [1s4U]-tRNAPhe cross-
linked to PheRS might be catalyzed either by the cross-linked
enzyme or by the signi¢cant amount of free PheRS. To ex-
clude the second possibility, aminoacylation was tested in the
presence of tRNAPhe lacking the 3P-terminal nucleotide (Fig.
3). Aminoacylation kinetics of the enzyme-cross-linked tRNA
was not a¡ected by addition of the excess of the unchargeable
tRNAPhe analog, while aminoacylation of free tRNAPhe was
considerably inhibited at identical conditions. Thus, amino-
acylation in the covalent complex was not abolished by sup-
pression of the activity of free enzyme in the same mixture,
indicating functional activity of the cross-linked enzyme.
For completely thiolated transcript, negligible level of phen-
ylalanylation of the PheRS-cross-linked tRNA was observed
(see Table 2). This loss of activity is probably associated with
inactivation of the bound tRNA analog, caused by cross-link-
ing reactions. [16s4U]-tRNAPhe irradiated but not linked to
PheRS was also examined for the acceptor activity and was
not aminoacylated at all conditions used. Previously, E. coli
tRNAPhe containing a single intramolecular cross-link be-
tween s4U8 and C13 has been shown to retain 75% of the
acceptor activity of the native tRNAPhe [20]. Many RNA-
RNA cross-links that can form the completely thiolated tran-
script, both free and enzyme-cross-linked, are likely to distort
tRNA conformation, resulting in inactivation.
The observed biological activity of the covalent complex of
PheRS with the s4U-monosubstituted tRNAPhe analog
strongly suggests that the cross-linked tRNA is located ex-
actly at the tRNA binding site, with the acceptor end of the
bound tRNA being properly positioned toward the catalytic
site of the enzyme. s4U-containing transcripts of tRNAPhe
should be useful for identifying the contact regions of PheRS
and tRNAPhe bound in a speci¢c complex in solution.
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